ghk cu copper peptide hair growth clinical trial randomized ghk-cu double blind ✨ More than — it's cellular support ✨ and restimulating the hair follicles Bloom Clinically Proven Copper GHK-CU

Its the result of an inspection that contains all sorts of FDA cGMP violations

Lung microbiome for clinicians

References Liu, X

It were analyzed by sampling the right lumbar level 4,5,6 dorsal root ganglion (RL4,5,6-DRG) and lumbar level 5 spinal cord (L5-SC) from 3 rats of control, morphine, 3 BPC-157 groups at 5 (representative value of phase 1) and 35 min (representative value of phase 2) after the formalin test

What they found: Plasma NAD+ did not rise directly , it was rapidly metabolized Plasma nicotinamide and methyl-nicotinamide rose markedly , markers of NAD+ metabolism NAD+ likely reaches tissues as its metabolites (not as whole NAD+) Clinically, patients subjectively reported increased energy during and after the infusion No serious adverse events during the 6-hour IV infusion Why it matters: The study provides rare clinical data on IV NAD+ , the administration route used by NAD+ clinics off-label